Park Place Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8K Hold
109
﹤0.01% 555
2025
Q4
$17.9K Hold
109
﹤0.01% 475
2025
Q3
$14.6K Sell
109
-68
-38% -$8.26K ﹤0.01% 497
2025
Q2
$22.4K Hold
177
0.01% 460
2025
Q1
$22.5K Buy
177
+68
+62% +$10.5K 0.01% 447
2024
Q4
$15.7K Sell
109
-77
-41% -$11K ﹤0.01% 512
2024
Q3
$27.7K Buy
186
+24
+15% +$3.44K 0.01% 457
2024
Q2
$20.4K Sell
162
-79
-33% -$12.4K 0.01% 500
2024
Q1
$44.3K Buy
241
+7
+3% +$1.33K 0.02% 415
2023
Q4
$42.1K Sell
234
-19
-8% -$2.96K 0.02% 440
2023
Q3
$40.2K Buy
253
+120
+90% +$19.6K 0.01% 511
2023
Q2
$18.8K Buy
+133
New +$21.3K 0.01% 669

Other funds holding RGEN

Park Place Capital's RGEN Position: Q1 2026 in Review

Park Place Capital held its Repligen (RGEN) position steady in Q1 2026 at 109 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #555.

Park Place Capital first reported a position in RGEN in Q2 2023 and has held it in 12 quarters since. The position peaked at $44.3K in Q1 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Park Place Capital held 109 shares of Repligen worth $12.8K as of Q1 2026.
  • Park Place Capital left its Repligen share count unchanged in Q1 2026.
  • Repligen made up ﹤0.01% of Park Place Capital's portfolio in Q1 2026, its #555 holding.
  • Park Place Capital first reported a position in Repligen in Q2 2023 and has held it in 12 quarters since.
  • Park Place Capital's Repligen position peaked at $44.3K in Q1 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.